Article ; Online: Oral amoxicillin/clavulanate for the prevention of bacteremia following dental extractions.
2022 Volume 29, Issue 5, Page(s) 2272–2276
Abstract: This study aimed to evaluate the effectiveness of oral amoxicillin/clavulanate (AMX-CL) for the prevention of bacteremia following dental extractions. The study group (AMX-CLG) comprised 40 adults requiring dental extractions under general anesthesia who ...
Abstract | This study aimed to evaluate the effectiveness of oral amoxicillin/clavulanate (AMX-CL) for the prevention of bacteremia following dental extractions. The study group (AMX-CLG) comprised 40 adults requiring dental extractions under general anesthesia who were administered a prophylactic regimen of 1875/125 mg of AMX-CL orally 1-2 h prior to the surgery. Venous blood samples were collected from each patient at baseline and at 30 s and 15 min after dental extractions. Samples were inoculated into BACTEC Plus culture bottles and processed in the BACTEC 9240. Conventional microbiological techniques were used for subcultures and further identification of the isolated bacteria. The results for the AMX-CLG were compared with those of a control group (CG; no prophylaxis) and an amoxicillin group (AMXG; 2 g of amoxicillin orally), consisting of randomly selected patients from among those participating in two clinical trials that we have previously published. The prevalence of bacteremia in the CG, AMXG, and AMX-CLG was 97%, 50%, and 15%, respectively, at 30 s after completing the extractions, and 67%, 10%, and 4% at 15 min, respectively, after the last extraction. The prevalence of bacteremia in the AMXG and the AMX-CLG at 30 s and at 15 min after completing the extractions was significantly lower than that in the CG (p < 0.001 and p < 0.001, respectively; Fisher's exact test). The prevalence of bacteremia in the AMX-CLG at 30 s after completing the extractions was significantly lower than that in the AMXG (p < 0.001; Fisher's exact test). Based in the results of this preliminary study, oral AMX-CL could be an excellent option for preventing bacteremia secondary to dental procedures in patients at risk. |
---|---|
MeSH term(s) | Adult ; Humans ; Tooth Extraction/adverse effects ; Amoxicillin/therapeutic use ; Amoxicillin-Potassium Clavulanate Combination/therapeutic use ; Bacteremia/prevention & control ; Bacteremia/epidemiology ; Bacteria ; Anti-Bacterial Agents/therapeutic use |
Chemical Substances | Amoxicillin (804826J2HU) ; Amoxicillin-Potassium Clavulanate Combination (74469-00-4) ; Anti-Bacterial Agents |
Language | English |
Publishing date | 2022-05-13 |
Publishing country | Denmark |
Document type | Journal Article |
ZDB-ID | 1290529-x |
ISSN | 1601-0825 ; 1354-523X |
ISSN (online) | 1601-0825 |
ISSN | 1354-523X |
DOI | 10.1111/odi.14221 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 4427: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.